Literature DB >> 16957604

Neurosteroids regulate mouse aggression induced by anabolic androgenic steroids.

Fabio Pibiri1, Marianela Nelson, Giovanni Carboni, Graziano Pinna.   

Abstract

Anabolic androgenic steroid abuse triggers impulsive aggression, anxiety, and depression, which suggests a dysfunction of GABAergic neurotransmission. Socially isolated female mice that have received testosterone propionate (1.45 micromol/kg) treatment for 3 weeks during social isolation express aggression, neurosteroid downregulation, and changes in the cortical mRNA expression of several gamma-aminobutyric acid type A receptor subunits (alpha1, alpha2, gamma2 are decreased by 30-40%, and alpha4 and alpha5 are increased by 50%). Administration of allopregnanolone or the potent selective brain steroidogenic stimulant S-norfluoxetine, in doses (1.8-3.6 micromol/kg) that fail to inhibit 5-hydroxytryptamine reuptake, normalizes olfactory bulb neurosteroid level downregulation and abolishes aggression. This work underscores the role of neurosteroids in the regulation of aggression elicited by testosterone propionate in socially isolated female mice.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16957604     DOI: 10.1097/01.wnr.0000234752.03808.b2

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  16 in total

1.  Chronic anabolic androgenic steroid exposure alters corticotropin releasing factor expression and anxiety-like behaviors in the female mouse.

Authors:  Beth A Costine; Joseph G Oberlander; Matthew C Davis; Carlos A A Penatti; Donna M Porter; Robert N Leaton; Leslie P Henderson
Journal:  Psychoneuroendocrinology       Date:  2010-05-26       Impact factor: 4.905

Review 2.  Mad men, women and steroid cocktails: a review of the impact of sex and other factors on anabolic androgenic steroids effects on affective behaviors.

Authors:  Marie M Onakomaiya; Leslie P Henderson
Journal:  Psychopharmacology (Berl)       Date:  2016-01-12       Impact factor: 4.530

Review 3.  Living or dying in three quarter time: neonatal orchestration of hippocampal cell death pathways by androgens and excitatory GABA.

Authors:  C D Foradori; R J Handa
Journal:  Exp Neurol       Date:  2008-05-11       Impact factor: 5.330

Review 4.  Neurosteroid, GABAergic and hypothalamic pituitary adrenal (HPA) axis regulation: what is the current state of knowledge in humans?

Authors:  Shannon K Crowley; Susan S Girdler
Journal:  Psychopharmacology (Berl)       Date:  2014-04-23       Impact factor: 4.530

Review 5.  How research on female vertebrates contributes to an expanded challenge hypothesis.

Authors:  Kimberly A Rosvall; Alexandra B Bentz; Elizabeth M George
Journal:  Horm Behav       Date:  2019-09-10       Impact factor: 3.587

6.  Enhanced fear responses in mice treated with anabolic androgenic steroids.

Authors:  Roberto Carlos Agis-Balboa; Fabio Pibiri; Marianela Nelson; Graziano Pinna
Journal:  Neuroreport       Date:  2009-04-22       Impact factor: 1.837

7.  γ-Aminobutyric acid neural signaling in the lateroanterior hypothalamus modulates aggressive behavior in adolescent anabolic/androgenic steroid-treated hamsters.

Authors:  Thomas R Morrison; Lesley A Ricci; Richard H Melloni
Journal:  Behav Pharmacol       Date:  2014-10       Impact factor: 2.293

Review 8.  Neurosteroids in the context of stress: implications for depressive disorders.

Authors:  Susan S Girdler; Rebecca Klatzkin
Journal:  Pharmacol Ther       Date:  2007-05-24       Impact factor: 12.310

Review 9.  Neurosteroid biosynthesis regulates sexually dimorphic fear and aggressive behavior in mice.

Authors:  Graziano Pinna; Roberto Carlos Agis-Balboa; Fabio Pibiri; Marianela Nelson; Alessandro Guidotti; Erminio Costa
Journal:  Neurochem Res       Date:  2008-05-13       Impact factor: 3.996

10.  Effects of chronic exposure to an anabolic androgenic steroid cocktail on alpha5-receptor-mediated GABAergic transmission and neural signaling in the forebrain of female mice.

Authors:  C A A Penatti; B A Costine; D M Porter; L P Henderson
Journal:  Neuroscience       Date:  2009-03-24       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.